2-[[benzyl(pyridin-3-ylmethyl)carbamothioyl]amino]-N-(2-methoxyethyl)acetamide
C19H24N4O2S — CID 5152118
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[benzyl(pyridin-3-ylmethyl)carbamothioyl]amino]-N-(2-methoxyethyl)acetamide
2-[[benzyl(pyridin-3-ylmethyl)carbamothioyl]amino]-N-(2-methoxyethyl)acetamide (PubChem CID 5152118) has the molecular formula C19H24N4O2S and a molecular weight of 372.49 g/mol. Its IUPAC name is 2-[[benzyl(pyridin-3-ylmethyl)carbamothioyl]amino]-N-(2-methoxyethyl)acetamide.
Molecular Properties
| Compound Name | 2-[[benzyl(pyridin-3-ylmethyl)carbamothioyl]amino]-N-(2-methoxyethyl)acetamide |
|---|---|
| PubChem CID | 5152118 |
| Molecular Formula | C19H24N4O2S |
| Molecular Weight | 372.49 g/mol |
| Exact Mass | 372.16 |
| IUPAC Name | 2-[[benzyl(pyridin-3-ylmethyl)carbamothioyl]amino]-N-(2-methoxyethyl)acetamide |
| SMILES | COCCNC(=O)CNC(=S)N(Cc1ccccc1)Cc1cccnc1 |
| InChI | InChI=1S/C19H24N4O2S/c1-25-11-10-21-18(24)13-22-19(26)23(14-16-6-3-2-4-7-16)15-17-8-5-9-20-12-17/h2-9,12H,10-11,13-15H2,1H3,(H,21,24)(H,22,26) |
| InChIKey | DDCDJPLFNXPCAU-UHFFFAOYSA-N |
| XLogP | 1.72 |
| TPSA | 66.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 372.49 |
| LogP ≤ 5 | 1.72 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 5152118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.